Leukocyte Telomere Length and Mortality in the National Health and Nutrition Examination Survey, 1999-2002

Epidemiology

Volumn 26, Issue 4, 2015, Pages 528-535

  Needham, Belinda L ^a   Rehkopf, David ^a   Adler, Nancy ^b   Gregorich, Steven ^b   Lin, Jue ^c   Blackburn, Elizabeth H ^c   Epel, Elissa S ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CELL AGING; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LEUKOCYTE; LEUKOCYTE TELOMERE LENGTH; MALE; MEXICAN AMERICAN; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; TELOMERE HOMEOSTASIS; VERY ELDERLY; CAUCASIAN; EPIDEMIOLOGY; ETHNOLOGY; METABOLISM; NEOPLASM; NUTRITION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TELOMERE; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LEUKOCYTES; MALE; MEXICAN AMERICANS; MIDDLE AGED; MORTALITY; NEOPLASMS; NUTRITION SURVEYS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TELOMERE; UNITED STATES;

EID: 84942786489     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000299     Document Type: Article

References (49)

1. Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 2005;579: 859-862.
2. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973;41:181-190.
3. Blackburn EH. The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review. Biochemistry (Mosc). 1997;62:1196-1201.
4. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 1992;89:10114-10118.
5. Blackburn EH. Telomere states and cell fates. Nature. 2000;408:53-56.
6. A rmanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet. 2012;13:693-704.
7. A ubert G, Lansdorp PM. Telomeres and aging. Physiol Rev. 2008;88: 557-579.
8. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet. 2001;358:472-473.
9. Brouilette SW, Moore JS, McMahon AD, et al.; West of Scotland Coronary Prevention Study Group. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet. 2007;369:107-114.
10. Fitzpatrick AL, Kronmal RA, Gardner JP, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007;165:14-21.
11. Willeit P, Willeit J, Brandstätter A, et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol. 2010;30: 1649-1656.
12. Zee RY, Castonguay AJ, Barton NS, Germer S, Martin M. Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a case-control study. Transl Res. 2010;155:166-169.
13. Salpea KD, Talmud PJ, Cooper JA, et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis. 2010;209:42-50.
14. von Zglinicki T, Serra V, Lorenz M, et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest. 2000;80:1739-1747.
15. Panossian LA, Porter VR, Valenzuela HF, et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging. 2003;24:77-84.
16. Yaffe K, Lindquist K, Kluse M, et al.; Health ABC Study. Telomere length and cognitive function in community-dwelling elders: findings from the Health ABC Study. Neurobiol Aging. 2011;32:2055-2060.
17. Willeit P, Willeit J, Mayr A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304:69-75.
18. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011;20:1238-1250.
19. Astrup AS, Tarnow L, Jorsal A, et al. Telomere length predicts all-cause mortality in patients with type 1 diabetes. Diabetologia. 2010;53:45-48.
20. C awthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393-395.
21. E pel E, Merkin SS, Cawthon R, et al. The rate of telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging. 2009;1:81-88.
22. Fitzpatrick AL, Kronmal RA, Kimura M, et al. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2011;66:421-429.
23. Honig LS, Kang MS, Schupf N, Lee JH, Mayeux R. Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol. 2012;69:1332-1339.
24. Kimura M, Hjelmborg J, Gardner J, et al. Short leukocyte telomeres forecast mortality: a study in elderly Danish twins. Am J Epidemiol. 2008;167:799-806.
25. L ee J, Sandford AJ, Connett JE, et al. The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PLoS One. 2012;7:e35567.
26. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol. 2006;60:174-180.
27. Weischer M, Bojesen SE, Cawthon RM, Freiberg JJ, Tybjærg-Hansen A, Nordestgaard BG. Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler Thromb Vasc Biol. 2012;32:822-829.
28. Bakaysa SL, Mucci LA, Slagboom PE, et al. Telomere length predicts survival independent of genetic influences. Aging Cell. 2007;6: 769-774.
29. Farzaneh-Far R, Cawthon RM, Na B, Browner WS, Schiller NB, Whooley MA. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol. 2008;28:1379-1384.
30. Weischer M, Nordestgaard BG, Cawthon RM, Freiberg JJ, Tybjærg-Hansen A, Bojesen SE. Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst. 2013;105:459-468.
31. Harris SE, Deary IJ, MacIntyre A, et al. The association between telomere length, physical health, cognitive ageing, and mortality in non-demented older people. Neurosci Lett. 2006;406:260-264.
32. N jajou OT, Hsueh WC, Blackburn EH, et al.; Health ABC study. Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci. 2009;64:860-864.
33. Strandberg TE, Saijonmaa O, Tilvis RS, et al. Association of telomere length in older men with mortality and midlife body mass index and smoking. J Gerontol A Biol Sci Med Sci. 2011;66:815-820.
34. Bischoff C, Petersen HC, Graakjaer J, et al. No association between telomere length and survival among the elderly and oldest old. Epidemiology. 2006;17:190-194.
35. A viv A. The epidemiology of human telomeres: faults and promises. J Gerontol A Biol Sci Med Sci. 2008;63:979-983.
36. A viv A, Valdes AM, Spector TD. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int J Epidemiol. 2006;35:1424-1429.
37. Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35:112-131.
38. N eedham BL, Adler N, Gregorich S, et al. Socioeconomic status, health behavior, and leukocyte telomere length in the National Health and Nutrition Examination Survey, 1999-2002. Soc Sci Med. 2013;85:1-8.
39. R ogot E, Feinleib M, Ockay KA, Schwartz SH, Bilgrad R, Patterson JE. On the feasibility of linking census samples to the National Death Index for epidemiologic studies: a progress report. Am J Public Health. 1983;73:1265-1269.
40. R ogot E, Sorlie PD, Johnson NJ. Life expectancy by employment status, income, and education in the National Longitudinal Mortality Study. Public Health Rep. 1992;107:457-461.
41. Sathiakumar N, Delzell E, Abdalla O. Using the National Death Index to obtain underlying cause of death codes. J Occup Environ Med. 1998;40:808-813.
42. L in J, Epel E, Cheon J, et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods. 2010;352:71-80.
43. C awthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e47.
44. N ational Center for Health Statistics. AnalytiCand reporting guidelines: The National Health and Nutrition Examination Survey (NHANES). Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2006.
45. Smith Sehdev AE, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med. 2001;161:277-284.
46. C hiang CL. Competing risks in mortality analysis. Annu Rev Public Health. 1991;12:281-307.
47. Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010;58:783-787.
48. Houben JM, Giltay EJ, Rius-Ottenheim N, Hageman GJ, Kromhout D. Telomere length and mortality in elderly men: the Zutphen Elderly Study. J Gerontol A Biol Sci Med Sci. 2011;66:38-44.
49. Willeit P, Willeit J, Kloss-Brandstatter A, Kronenberg F, Kiechl S. Fifteenyear follow-up of association between telomere length and incident cancer and cancer mortality. JAMA. 2011;306:42-44.